Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.

Koga T, Abe T, Inoue H, Takenouchi T, Kitayama A, Yoshida T, Masuda N, Sugihara C, Kakuta M, Nakagawa M, Shibayama T, Matsushita Y, Hirota T, Ohya S, Utsui Y, Fukuoka T, Kuwahara S.

Antimicrob Agents Chemother. 2005 Aug;49(8):3239-50.

2.

Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds.

Hotoda H, Daigo M, Furukawa M, Murayama K, Hasegawa CA, Kaneko M, Muramatsu Y, Ishii MM, Miyakoshi S, Takatsu T, Inukai M, Kakuta M, Abe T, Fukuoka T, Utsui Y, Ohya S.

Bioorg Med Chem Lett. 2003 Sep 1;13(17):2833-6.

PMID:
14611839
3.

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.

Hotoda H, Furukawa M, Daigo M, Murayama K, Kaneko M, Muramatsu Y, Ishii MM, Miyakoshi S, Takatsu T, Inukai M, Kakuta M, Abe T, Harasaki T, Fukuoka T, Utsui Y, Ohya S.

Bioorg Med Chem Lett. 2003 Sep 1;13(17):2829-32.

PMID:
14611838
4.

Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.

Koga T, Inoue H, Ishii C, Okazaki Y, Domon H, Utsui Y.

J Antimicrob Chemother. 2002 Jul;50(1):133-6.

PMID:
12096020
5.

[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].

Kawada H, Kitayama A, Fukuoka T, Ishii C, Abe T, Kakuta M, Domon H, Ohya S, Utsui Y.

Jpn J Antibiot. 1999 Aug;52(8):533-40. Japanese.

PMID:
10587878
6.

[Combination effect of teicoplanin and panipenem on highly resistant strains of MRSA].

Utsui Y, Ishii C, Abe T, Kakuta M, Ohya S.

Jpn J Antibiot. 1999 Mar;52(3):268-77. Japanese.

PMID:
10367264
7.

Interactions of plaunotol with bacterial membranes.

Koga T, Watanabe H, Kawada H, Takahashi K, Utsui Y, Domon H, Ishii C, Narita T, Yasuda H.

J Antimicrob Chemother. 1998 Aug;42(2):133-40.

PMID:
9738829
8.

In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.

Fukuoka T, Ohya S, Utsui Y, Domon H, Takenouchi T, Koga T, Masuda N, Kawada H, Kakuta M, Kubota M, Ishii C, Ishii C, Sakagawa E, Harasaki T, Hirasawa A, Abe T, Yasuda H, Iwata M, Kuwahara S.

Antimicrob Agents Chemother. 1997 Dec;41(12):2652-63.

9.

[Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].

Fukuoka T, Domon H, Kakuta M, Ishii C, Hirasawa A, Utsui Y, Ohya S, Yasuda H.

Jpn J Antibiot. 1997 Apr;50(4):411-9. Japanese.

PMID:
9192249
10.

Bactericidal effect of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori.

Koga T, Kawada H, Utsui Y, Domon H, Ishii C, Yasuda H.

J Antimicrob Chemother. 1996 Sep;38(3):387-97.

PMID:
8889714
11.

In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori.

Koga T, Kawada H, Utsui Y, Domon H, Ishii C, Yasuda H.

J Antimicrob Chemother. 1996 May;37(5):919-29.

PMID:
8737142
12.
13.

Thiomarinol, a new hybrid antimicrobial antibiotic produced by a marine bacterium. Fermentation, isolation, structure, and antimicrobial activity.

Shiozawa H, Kagasaki T, Kinoshita T, Haruyama H, Domon H, Utsui Y, Kodama K, Takahashi S.

J Antibiot (Tokyo). 1993 Dec;46(12):1834-42.

14.

Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureus.

Hori S, Ohshita Y, Utsui Y, Hiramatsu K.

Antimicrob Agents Chemother. 1993 Nov;37(11):2278-84.

15.

Direct radioimmunoassay for haloperidol in human serum.

Terauchi Y, Ishikawa S, Oida S, Nakao M, Kagemoto A, Oida T, Utsui Y, Sekine Y.

J Pharm Sci. 1990 May;79(5):432-6.

PMID:
2352164
16.

In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.

Utsui Y, Inoue M, Mitsuhashi S.

Antimicrob Agents Chemother. 1987 Jul;31(7):1085-92.

17.

Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus.

Utsui Y, Ohya S, Magaribuchi T, Tajima M, Yokota T.

Antimicrob Agents Chemother. 1986 Dec;30(6):917-22.

18.
19.

Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.

Yokota T, Yoshida R, Utsui Y, Tajima M.

Drugs Exp Clin Res. 1985;11(1):29-38.

PMID:
3915273
20.

[Sensitive determination of haloperidol in human serum by radioimmunoassay].

Terauchi Y, Watari S, Utsui Y, Sekine Y.

Radioisotopes. 1984 Jun;33(6):376-9. Japanese.

PMID:
6494493
21.

Release of lipoteichoic acid from Staphylococcus aureus by treatment with cefmetazole and other beta-lactam antibiotics.

Utsui Y, Ohya S, Takenouchi Y, Tajima M, Sugawara S, Deguchi K, Suginaka H.

J Antibiot (Tokyo). 1983 Oct;36(10):1380-6.

22.

Penem derivatives: beta-lactamase stability and affinity for penicillin-binding proteins in Escherichia coli.

Ohya S, Utsui Y, Sugawara S, Yamazaki M.

Antimicrob Agents Chemother. 1982 Mar;21(3):492-7.

23.

Evidence for a synergistic interaction between phenytoin and phenobarbital in experimental animals.

Masuda Y, Utsui Y, Shiraishi Y, Karasawa T, Yoshida K, Shimizu M.

J Pharmacol Exp Ther. 1981 Jun;217(3):805-11.

PMID:
7230008
24.

Determination of haloperidol in human serum by radioimmunoassay.

Suzuki H, Minaki Y, Iwaisaki M, Sekine Y, Kagemoto A, Utsui Y, Hashimoto M, Yagi G, Itoh H.

J Pharmacobiodyn. 1980 May;3(5):250-7.

PMID:
7411387
26.

Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.

Hashimoto M, Sekine Y, Muto J, Yamaguchi T, Maeda T, Utsui Y, Yoshida K, Arakawa S, Shimokawa N, Shimakawa K.

Drug Metab Dispos. 1979 Nov-Dec;7(6):435-41. No abstract available.

PMID:
43234
27.

Pharmacokinetic and pharmacodynamic tolerance of a new anticonvulsant agent (3-sulfamoylmethyl-1,2-benzisoxazole) compared to phenobarbital, diphenylhydantoin and carbamazepine in rats.

Masuda Y, Utsui Y, Shiraishi Y, Karasawa T, Yoshida K, Shimizu M.

Arch Int Pharmacodyn Ther. 1979 Jul;240(1):79-89. No abstract available.

PMID:
507999
28.

Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. II. Urinary metabolites.

Hashimoto M, Miyazaki H, Nambu K, Fujii T, Arakawa S, Yoshida K, Utsui Y.

Drug Metab Dispos. 1979 Jan-Feb;7(1):20-3.

PMID:
35321
29.
30.
31.

[Bacteriological studies of butirosin sulfate, a new aminoglycoside antibiotic (author's transl)].

Otsuki M, Utsui Y, Kawamuro A, Fukao K, Nakazawa S.

Jpn J Antibiot. 1975 Oct;28(5):657-64. Japanese. No abstract available.

PMID:
51941
32.

[Gas chromatography of some nitrofuran derivatives].

Nakamura K, Utsui Y, Ninomiya Y.

Yakugaku Zasshi. 1966 May;86(5):404-9. Japanese. No abstract available.

PMID:
6011005
33.

[Studies on the constituent of Corydalis sps. I. Application of thin-layer-and gas-chromatography to Corydalis alkaloids].

Iwasa J, Naruto S, Utsui Y.

Yakugaku Zasshi. 1966 May;86(5):396-9. Japanese. No abstract available.

PMID:
6011003

Supplemental Content

Support Center